Reaction Details  Report a problem with these data
Target
Galectin-1
Ligand
BDBM50272258
Substrate
n/a
Meas. Tech.
ChEMBL_510247 (CHEMBL1005625)
IC50
5000000±n/a nM
Citation
 Giguère, D; Bonin, MA; Cloutier, P; Patnam, R; St-Pierre, C; Sato, S; Roy, R Synthesis of stable and selective inhibitors of human galectins-1 and -3. Bioorg Med Chem 16:7811-23 (2008) [PubMed]  Article
Target
Name:
Galectin-1
Synonyms:
14 kDa lectin | Galaptin | HPL | LEG1_HUMAN | LGALS1 | Lactose-binding lectin 1 | Lectin galactoside-binding soluble 1 | Putative MAPK-activating protein PM12
Type:
beta galactoside-binding protein
Mol. Mass.:
14713.53
Organism:
Homo sapiens (Human)
Description:
P09382
Residue:
135
Sequence:
MACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD
  
Inhibitor
Name:
BDBM50272258
Synonyms:
(2R,3R,4R,5R,6S)-2-(hydroxymethyl)-6-(2-(3-nitrophenyl)allyl)-tetrahydro-2H-pyran-3,4,5-triol | CHEMBL524323
Type:
Small organic molecule
Emp. Form.:
C15H19NO7
Mol. Mass.:
325.3139
SMILES:
OC[C@H]1O[C@@H](CC(=C)c2cccc(c2)[N+]([O-])=O)[C@H](O)[C@@H](O)[C@H]1O |r|
Structure:
Search PDB for entries with ligand similarity: